Why Cambrex Corporation Soared

On Tuesday's edition of Market Checkup, Motley Fool health-care analyst David Williamson takes a look at the biggest winners and losers in health care stocks today.

Shares of Cambrex Corporation (NYSE: CBM  ) soared Tuesday, up 15% for the day. News on Monday broke that the company recently passed an FDA manufacturing inspection for its plant in Iowa, and today the stock was upgraded to "overweight" by a company called First Analysis, because of increased confidence that the company would close a large API manufacturing deal with Gilead (NASDAQ: GILD  ) for its hepatitis C drug Sovaldi. There is also the belief that Gilead would give Cambrex preference for future drug opportunities.

In this segment, David discusses why this deal could be a huge deal for the company, and why, when he started digging into Cambrex, he liked what he saw.

So what's the best way for investors to play the biotech space today?
The best way to play the biotech space is to find companies that shun the status quo and instead discover revolutionary, groundbreaking technologies. In The Motley Fool's brand-new free report "2 Game-Changing Biotechs Revolutionizing the Way We Treat Cancer," find out about a new technology that big pharma is endorsing through partnerships, and the two companies that are set to profit from this emerging drug class. Click here to get your copy today.


Read/Post Comments (0) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2813919, ~/Articles/ArticleHandler.aspx, 8/21/2014 4:45:34 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement